The Nobel Prize team help Asclepius build a blockchain medical ecosystem
In 2020, COVID-19 has brought unprecedented impact on the world economy and politics, with a total of 170 million confirmed cases and more than 3.8 million deaths so far. Under the epidemic, people begin to pay more attention to and think about medical privacy, medical health, medical security and other issues
According to IDC, the global medical data will reach 40 trillion GB by the end of 2021, which is 30 times more than that of 2021. The explosive increase of medical information has not been matched by security measures. In addition, in the medical field, medical insurance premium is high, insurance is difficult, and reimbursement is slow; Medical information is blocked and not shared, which seriously restricts the development of global medical service.
*WHAT IS Asclepius*
Asclepius is a project founded by a group of Nobel laureates,in order to deal with many problems in medical field. Asclepius is a parallel medical smart public chain project deployed on the Polkadot trunk chain. Its team members include Andre Geim, “the father of Graphene” and the 2010 Nobel Prize winner in physics and George Fitzgerald Smoot, the creator of the theory of cosmic embryology, as well as many other Nobel Prize winners and members of the Academy of Sciences from various countries.
Asclepius establishes a perfect medical ecological circulation system by combining medical care and blockchain technology, to help the upstream and downstream of the medical industry to establish a one-stop smart contract platform, including Token issuance, DAPP development and NFT asset issuance.
Chinese Internet medical companies alone have burned through $200 billion in venture capital since the concept of Internet medical emerged in 2015. But even industry leader “Pingan Good Doctor”, which is listed in Hong Kong, has failed to make a profit. One of the most important reasons is that the current Internet medical care simply makes the traditional treatment online, without effectively solving many problems in the traditional medical treatment and without a clear business model.
Asclepius’s SOLUTION
In Asclepius, patients, doctors, insurance institutions and researchers are all involved in ecological construction in their own way. Around the model of Polkadot ecology, Asclepius breaks down the barriers between medical data and builds a bridge between Asclepius smart medical platform and medical institutions. It can provide chain services for patients, doctors, hospitals, technology service providers, insurance companies, gene companies, health management institutions and other data demanders in the medical ecosystem.
In the traditional medical industry, patients only pay money to obtain the corresponding treatment when they ask for medical treatment, but the medical data originally belonging to the patients themselves do not go to them. Even worse, the information may be sold for others’ profit. In the Asclepius ecosystem, the ownership of all medical data will belong to the patients themselves through the way of on-chain right determination. Any medical or research institution that wants to obtain patient data needs to publish corresponding tasks in Asclepius, clarify the use of data and the payment for provided data. Patients who meet the corresponding conditions will be rewarded with corresponding tokens provided by the task issuer when they authorize on the chain.
Doctors and researchers in the medical industry can also establish their own community in Asclepius, make use of their professional knowledge to popularize science, and attract the attention of related patients with knowledge lectures to get token rewards from patients. At the same time, patients can choose to authorize their relevant medical information to researchers to obtain exclusive NFT products issued by researchers, and patients can consult and communicate with experts and scholars in related fields by using relevant NFT products.
NFT can also be used to improve the shortcomings of medical insurance. Traditional insurance content is too rigid, and patients can only choose the medical insurance products already launched by medical insurance companies, which cannot meet the customized needs according to their own conditions. Asclepius breaks down the specific insurance measures in the traditional policy, and each specific insurance content is issued in the form of NFT on the chain. Patients can choose to buy insurance services that better suit their needs. In the reimbursement stage, the traditional paper or electronic reimbursement certificate will be replaced by NFT. Users only need to show the medical certificate and their NFT insurance policy to the insurance institution on the chain. The insurance institution will automatically execute the smart contract written in advance and return the corresponding reimbursement expense to the address of the patient.
Asclepius DAO creates exclusive NFT — DEX (innovative drug patent + non-fungibe token exchange protocol for specific medical services). Researchers create NFT products in the Asclepius DAO that correspond to their new drug research institutes. Patients and other researchers in the Asclepius ecosystem can obtain the corresponding NFT by completing corresponding tasks published by the researchers (such as contributing their medical data, providing research equipment, and helping organize and analyze data). NFT can be traded with stable coin on the NFT-DEX platform at any time. While protecting pharmaceutical patents, the market determines the value of pharmaceutical patents, and the creators of pharmaceutical patents can clearly see the market response and promote the upgrading of their own research and development capabilities, so as to promote the progress of medical level.
Asclepius’s PROSPECT
According to the official announcement, Asclepius’s limited medical ecology public chain network which is based on the Substrate framework has been tested since May.
Other aspects of Asclepius’ development are also moving forward. From this, we can see that, the professional team, composed of several Nobel laureates and academicians of Academy of Sciences from various countries, not only have profound attainments in the traditional medical field, but also can not be underestimated in the blockchain technology. Of course, it’s hard to say how much success Asclepius will have in such a highly specialized field. But compared with other medical blockchain projects, it is reasonable to believe that Asclepius will become the leading project in this professional field with its own strong strength and innovative ideas!